Search the MBS

Characterisation of germline gene mutations, requested by a specialist or consultant physician, including copy number variation in BRCA1 and BRCA2 genes and one or more of the following genes STK11, PTEN, CDH1, PALB2, or TP53 in a patient with breast or ovarian cancer for whom clinical and family history criteria, as assessed by the specialist or consultant physician who requests the service using a quantitative algorithm, place the patient at >10% risk of having a pathogenic mutation identified in one or more of the genes specified above.

Fee: $1,200.00 Benefit: 75% = $900.00 85% = $1,115.30

(See para PN.0.27 of explanatory notes to this Category)

• Previous - Item 73295
• Next - Item 73297